Skip to main content
Fig. 2 | Experimental Hematology & Oncology

Fig. 2

From: Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing

Fig. 2

BCMA positive and negative relapses occur concurrently in at relapse after BCMA CAR-T cell therapy in R/R-MM. A The UMAP plots of B/plasma cells at baseline and progression. B Dot plot of differentially expressed genes in each cluster. C The proportions of B/plasma cells of all the clusters at baseline and progression. D The violin diagram of BCMA, CD38, CD24, SLAMF7, CD138, and GPRC5D expression in each B/plasma cell cluster. E The proportion of plasma cell cluster at baseline and progression. F The enrichment of KEGG pathway in each cluster of B/plasma cells

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us